(As of June 30, 2024)
| Securities code | 4578 |
|---|---|
| Stock exchange listing | Tokyo Stock Exchange, prime Market |
| Business Category | Pharmaceuticals |
| Capital | ¥81.69 billion |
| Stock trading unit | 100 shares |
| Number of shares authorized | 1,600,000,000 |
| Number of shares issued | 557,835,617 |
| Number of shareholders | 70,308 |
| Fiscal year | From January 1 to December 31 of the same year |
| Annual shareholders' meeting | March each year |
| Record dates | Annual shareholders' meeting and year-end dividend payment: December 31 Interim dividend payment: June 30 |
| Shareholder registrar Administrative institution for special accounts |
Mitsubishi UFJ Trust and Banking Corporation |
| Contact information | Securities Agency Department, Mitsubishi UFJ Trust and Banking Corporation P.O. Box 29, Shin-Tokyo Post Office, 137-8081, Japan Tel: +81-120-232-711 (Business hours: 9:00 a.m. - 5:00 p.m., JST; closed Saturdays, Sundays, and national holidays) |
| Method of public notice | Public notices shall be posted electronically on the Company's website. If this is not possible due to unavoidable reasons such as a system failure, public notices shall be published in the Nihon Keizai Shimbun. |